JUAN JOSÉ
PICAZO DE LA GARZA
Researcher in the period 2009-2018
Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (10)
2017
-
Epidemiology of otitis media with spontaneous perforation of the tympanic membrane in young children and association with bacterial nasopharyngeal carriage, recurrences and pneumococcal vaccination in Catalonia, Spain - The prospective hermes study
PLoS ONE, Vol. 12, Núm. 2
-
Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children
Vaccine, Vol. 35, Núm. 35, pp. 4646-4651
2013
-
Expansion of serotype coverage in the universal pediatric vaccination calendar: Short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain
Clinical and Vaccine Immunology, Vol. 20, Núm. 10, pp. 1524-1530
-
Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011
Pediatric Infectious Disease Journal
-
Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008-2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines
BMC Infectious Diseases, Vol. 13, Núm. 1
-
Rapid diagnosis of invasive pneumococcal disease in pediatric population
Journal of Microbiological Methods, Vol. 93, Núm. 2, pp. 116-120
2011
-
Clonal and clinical profile of Streptococcus pneumoniae serotype 19A causing pediatric invasive infections: A 2-year (2007-2009) laboratory-based surveillance in Madrid
Vaccine, Vol. 29, Núm. 9, pp. 1770-1776
-
Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid
Pediatric Infectious Disease Journal, Vol. 30, Núm. 6, pp. 471-474
-
Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar
Clinical and Vaccine Immunology, Vol. 18, Núm. 1, pp. 89-94